Back to MW MARSHALL WACE, LLP

KPTIKPTI
Showing 8 of 23 quarters

Position history for MWMARSHALL WACE, LLP's holdings in KARYOPHARM THERAPEUTICS INC

MARSHALL WACE, LLP holds 128,451 shares of KPTI (KARYOPHARM THERAPEUTICS INC), worth $715,472 as of 2026-Q1. KPTI represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$715,472

Current Shares

128,451

Total Value Change

-$1.5M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
128,451
0.0%
$715,4720.0%$9.13
0
2025-Q4
Unchanged
128,451
0.0%
$945,4000.0%$7.31
0
2025-Q3
Unchanged
128,451
0.0%
$840,0700.0%$6.35
0
2025-Q2
Unchanged
128,451
0.0%
$553,6240.0%$4.39
0
2025-Q1
Decreased
128,451
-94.7%
$480,4070.0%$4.16
0
2024-Q4
Increased
2.4M
+15.3%
$1.6M0.0%$10.50
29
2024-Q3
Decreased
2.1M
-19.3%
$1.7M0.0%$10.86
0
2024-Q2
Decreased
2.6M
-0.6%
$2.2M0.0%$13.02
0

Other major holders of KPTI: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used